# US 2025/0163041 A1 · Azacycloalkyl carbonyl cyclic amine compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0163041 A1
- Document ID: US20250163041A1
- Status: Published application
- Kind: A1
- Application number: 18/970,835
- Filed: 2024-12-05
- Published: 2025-05-22
- Earliest claimed: 2022-06-13
- Assignees: Alivexis, Inc.; Astellas Pharma Inc.
- Applicants: Alivexis, Inc.; Astellas Pharma Inc.
- Inventors: Takafumi SHIMIZU; Yoh TERADA; Takeo URAKAMI; William SINKO; Jun MAEDA; Tsubasa WATANABE; Hiroaki YAMAGISHI
- Web page: https://patentgrep.com/patent/US20250163041A1

## CPC

- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C07D 413/14: containing three or more hetero rings
- A61K 31/4545: containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
- A61K 31/506: not condensed and containing further heterocyclic rings
- A61K 31/5377: not condensed and containing further heterocyclic rings, e.g. timolol
- C07D 401/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 401/14: containing three or more hetero rings
- C07D 417/14: containing three or more hetero rings
- C07D 453/06: containing isoquinuclidine ring systems
- C07D 471/08: Bridged systems
- C07D 491/044: with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D 491/107: with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Provided is an azacycloalkylcarbonyl cyclic amine compound which is useful as an active ingredient in a pharmaceutical composition for a treatment of a neutrophil associated inflammatory disease. The azacycloalkylcarbonyl cyclic amine compound of the present invention is a compound of Formula (I) or a salt thereof. (in the formula, Ring A represents azacycloalkyl which may have a substituent and may be spiro-fused; Y represents alkyl which may have a substituent, cycloalkyl which may have a substituent, or the like; L represents a nitrogen-containing aromatic heterocycle or the like; Z represents cycloalkyl which may have a substituent, an aromatic hydrocarbon ring which may have a substituent, a non-aromatic heterocycle which may have a substituent, or the like; and m and n each independently represent an integer of 1 or 2.)

## Claims

### Claim 1

A compound of Formula (I) or a salt thereof,
wherein:
Ring A is 9-hydroxy-6-azaspiro[3.5]nonan-7-yl which may have a substituent, 4-hydroxy-5,5-dimethylpiperidin-2-yl which may have a substituent, or 1-oxa-6-azaspiro[3.5]nonan-7-yl which may have a substituent;
Y is hydrogen, alkyl which may have a substituent, C3-6 cycloalkyl which may have a substituent, an aromatic hydrocarbon ring which may have a substituent, a non-aromatic heterocycle which may have a substituent, an aromatic heterocycle which may have a substituent, or —N(RY1)—RY2;
one of RY1 and RY2 is C1-4 alkyl which may have a substituent, and the other is C1-4 alkyl which may have a substituent, —C(═O)—(C1-4 alkyl), or —S(═O)2—(C1-4 alkyl);
L is a nitrogen-containing aromatic heterocycle which may have a substituent, a nitrogen-containing aromatic heterocycle-(C1-2 alkylene) which may have a substituent, —C(═O)—N(RL1)—, —C(═O)—N(RL1)—(C1-2 alkylene), —C(═O)—, or a nitrogen-containing aromatic heterocycle-C(═O)— which may have a substituent;
RL1 is hydrogen, or C1-4 alkyl which may have a substituent;
Z is cycloalkyl which may have a substituent, an aromatic hydrocarbon ring which may have a substituent, a non-aromatic heterocycle which may have a substituent, an aromatic heterocycle which may have a substituent, or —O-(alkyl which may have substituent),
with the proviso that when L is —C(═O)— or a nitrogen-containing aromatic heterocycle-C(═O)— which may have a substituent, Z is cyclic amino which may have a substituent; and
m and n are each independently 1 or 2.

### Claim 2 (depends on 1)

The compound of claim 1 or the salt thereof, wherein the Ring A is (7S,9R)-9-hydroxy-6-azaspiro[3.5]nonan-7-yl which may have a substituent.

### Claim 3 (depends on 1)

The compound of claim 1 or the salt thereof,
wherein the Ring A is (2S,4R)-4-hydroxy-5,5-dimethylpiperidin-2-yl which may have a substituent.

### Claim 4 (depends on 1)

The compound of claim 1 or the salt thereof,
wherein the Ring A is (4R,7S)-1-oxa-6-azaspiro[3.5]nonan-7-yl which may have a substituent.

### Claim 5 (depends on 1)

The compound of claim 1 or the salt thereof, wherein m is 2 and n is 2.

### Claim 6 (depends on 1)

The compound of claim 1 or the salt thereof, wherein L is a nitrogen-containing aromatic heterocycle which may have a substituent.

### Claim 7 (depends on 6)

The compound of claim 6 or the salt thereof, wherein L is 1,2,4-oxadiazole or tetrazole.

### Claim 8 (depends on 1)

The compound of claim 1 or the salt thereof, wherein Y is alkyl which may have a substituent or C3-6 cycloalkyl which may have a substituent.

### Claim 9 (depends on 1)

The compound of claim 1 or the salt thereof, wherein Z is cycloalkyl which may have a substituent or a non-aromatic heterocycle which may have a substituent.

### Claim 10 (depends on 9)

The compound of claim 9 or the salt thereof, wherein Z is cyclobutyl, cyclohexyl, or tetrahydropyranyl, each of which is substituted with 2 or 3 substituents selected from fluoro and methyl.

### Claim 11 (depends on 1)

The compound of claim 1 or the salt thereof, wherein Y is hydrogen.

### Claim 12 (depends on 11)

The compound of claim 11 or the salt thereof,
wherein Z is phenyl which may be substituted with 1 to 3 substituents selected from fluoro, methyl, and trifluoromethyl.

### Claim 13 (depends on 1)

The compound of claim 1 or the salt thereof, wherein the compound is of Formula (Ia) or (Ib) or a salt thereof,
R1 and R2 are each methyl, or
R1 and R2 together with a carbon atom adjacent thereto form cyclobutane:
wherein, in the formula, a wavy line is a bonding point with a remaining portion of the compound;
Y is hydrogen, C1-4 alkyl which may have a substituent, C3-6 cycloalkyl which may have a substituent, an aromatic hydrocarbon ring which may have a substituent, a non-aromatic heterocycle which may have a substituent, or an aromatic heterocycle which may have a substituent; and
Z is C3-6 cycloalkyl which may have a substituent, an aromatic hydrocarbon ring which may have a substituent, a non-aromatic heterocycle which may have a substituent, an aromatic heterocycle which may have a substituent, or —O-(alkyl which may have substituent).

### Claim 14 (depends on 13)

The compound of claim 13 or the salt thereof,
wherein the compound is of Formula (Iaa) or a salt thereof,
wherein R1 and R2 are each methyl.

### Claim 15 (depends on 13)

The compound of claim 13 or the salt thereof, wherein:
Y is hydrogen, C1-4 alkyl which may be substituted with 1 to 5 halogens, or C3-6 cycloalkyl;
L is a nitrogen-containing aromatic heterocycle which may have a substituent, or a nitrogen-containing aromatic heterocycle-(C1-2 alkylene) which may have a substituent; and
Z is C3-6 cycloalkyl which may have a substituent, phenyl which may have a substituent, a non-aromatic heterocycle which may have a substituent, or an aromatic heterocycle which may have a substituent.

### Claim 16 (depends on 13)

The compound of claim 13 or the salt thereof, wherein:
Y is hydrogen, C1-4 alkyl which may be substituted with 1 to 5 halogens, or C3-6 cycloalkyl;
L is a nitrogen-containing aromatic heterocycle or a nitrogen-containing aromatic heterocycle-(C1-2 alkylene); and
Z is C3-6 cycloalkyl, phenyl, a non-aromatic heterocycle, or an aromatic heterocycle, wherein the C3-6 cycloalkyl, the phenyl, the non-aromatic heterocycle, and the aromatic heterocycle in Z may be each substituted with one or more substituents selected from halogen, —OH, amino, cyano, nitro, —C(═O)—(C1-4 alkyl), —C(═O)—OH, —C(═O)—O—(C1-4 alkyl), —C(═O)-amino, C1-4 alkyl which may be substituted with halogen, and —O—(C1-4 alkyl which may be substituted with halogen).

### Claim 17 (depends on 16)

The compound of claim 16 or the salt thereof, wherein L is selected from pyrrole, pyrazole, imidazole, 1,3-oxazole, 1,3-thiazole, 1,2,4-oxadiazole, 1,3,4-oxadiazole, 1,2,4-thiadiazole, 1,3,4-thiadiazole, 1,2,3-triazole, 1,2,4-triazole, tetrazole, pyridine, pyridazine, pyrimidine, and pyrazine.

### Claim 18 (depends on 1)

A pharmaceutical composition comprising the compound of claim 1 or the salt thereof, and a pharmaceutically acceptable excipient.

### Claim at position 19

19-22. (canceled)

### Claim 23 (depends on 1)

A method for treating a neutrophil associated inflammatory disease, the method comprising administering an effective amount of the compound of claim 1 or the salt thereof to a subject in need thereof.

### Claim 24 (depends on 2)

The compound of claim 2 or the salt thereof, wherein the compound is selected from:
or a salt thereof.

### Claim 25 (depends on 3)

The compound of claim 3 or the salt thereof, wherein the compound is selected from:
or a salt thereof.

### Claim 26 (depends on 4)

The compound of claim 4 or the salt thereof, wherein the compound is selected from:
or a salt thereof.

### Claim 27 (depends on 13)

The compound of claim 13 or the salt thereof, wherein the compound is of Formula (Iaa) or a salt thereof,
wherein R1 and R2 together with a carbon atom adjacent thereto form cyclobutane:

### Claim 28 (depends on 13)

The compound of claim 13 or the salt thereof, wherein the compound is of Formula (Ibb) or a salt thereof,

### Claim 29 (depends on 15)

The compound of claim 15 or the salt thereof, wherein Y is C1-4 alkyl which may be substituted with 1 to 5 halogens.

### Claim 30 (depends on 29)

The compound of claim 29 or the salt thereof, wherein Z is C3-6 cycloalkyl which may have a substituent, or a non-aromatic heterocycle which may have a substituent.

### Claim 31 (depends on 15)

The compound of claim 15 or the salt thereof, wherein Y is H.

### Claim 32 (depends on 31)

The compound of claim 31 or the salt thereof, wherein Z is phenyl which may have a substituent, or an aromatic heterocycle which may have a substituent.

### Claim 33

A compound of Formula (I) or a salt thereof,
wherein:
Ring A is azacycloalkyl which may have a substituent and may be spiro-fused with C3-6 cycloalkyl or a saturated heterocycle having 3 to 6 ring members;
Y is hydrogen, alkyl which may have a substituent, C3-6 cycloalkyl which may have a substituent, an aromatic hydrocarbon ring which may have a substituent, a non-aromatic heterocycle which may have a substituent, an aromatic heterocycle which may have a substituent, or —N(RY1)—RY2;
one of RY1 and RY2 is C1-4 alkyl which may have a substituent, and the other is C1-4 alkyl which may have a substituent, —C(═O)—(C1-4 alkyl), or —S(═O)2—(C1-4 alkyl);
L is a nitrogen-containing aromatic heterocycle which may have a substituent, or a nitrogen-containing aromatic heterocycle-(C1-2 alkylene) which may have a substituent;
RL1 is hydrogen, or C1-4 alkyl which may have a substituent;
Z is cycloalkyl which may have a substituent, an aromatic hydrocarbon ring which may have a substituent, a non-aromatic heterocycle which may have a substituent, an aromatic heterocycle which may have a substituent, or —O-(alkyl which may have substituent),
with the proviso that when L is —C(═O)— or a nitrogen-containing aromatic heterocycle-C(═O)— which may have a substituent, Z is cyclic amino which may have a substituent; and
m and n are each independently 1 or 2.

### Claim 34 (depends on 33)

The compound of claim 33 or the salt thereof, wherein L is pyrrole, pyrazole, imidazole, 1,3-oxazole, 1,3-thiazole, 1,2,4-oxadiazole, 1,3,4-oxadiazole, 1,2,4-thiadiazole, 1,3,4-thiadiazole, 1,2,3-triazole, 1,2,4-triazole, tetrazole, pyridine, pyridazine, pyrimidine, or pyrazine.
